Dr. Bernard Partiula, D.O
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $619.51 | 24 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $162.46 | 3 | $0 (2018) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $119.27 | 7 | $0 (2024) |
| Gilead Sciences, Inc. | $93.20 | 2 | $0 (2021) |
| Alnylam Pharmaceuticals Inc. | $42.47 | 2 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $38.73 | 2 | $0 (2018) |
| ORPHALAN INC | $30.07 | 1 | $0 (2024) |
| QOL Medical, LLC | $27.48 | 2 | $0 (2023) |
| INTERCEPT PHARMACEUTICALS, INC. | $25.88 | 1 | $0 (2022) |
| Takeda Pharmaceuticals U.S.A., Inc. | $22.36 | 1 | $0 (2022) |
| Melinta Therapeutics, LLC | $22.13 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $90.74 | 4 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($39.03) |
| 2023 | $63.43 | 4 | QOL Medical, LLC ($27.48) |
| 2022 | $141.00 | 7 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($50.29) |
| 2021 | $40.39 | 2 | Gilead Sciences, Inc. ($22.30) |
| 2020 | $82.76 | 2 | Gilead Sciences, Inc. ($70.90) |
| 2018 | $201.19 | 5 | Janssen Pharmaceuticals, Inc ($162.46) |
All Payment Transactions
24 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/27/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $21.89 | General |
| Category: Gastroenterology | ||||||
| 10/18/2024 | ORPHALAN INC | CUVRIOR (Drug) | Food and Beverage | In-kind items and services | $30.07 | General |
| Category: Hepatology | ||||||
| 10/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), PLENVU | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: Gastroenterology | ||||||
| 08/01/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $21.64 | General |
| Category: Rare Disease | ||||||
| 10/06/2023 | Melinta Therapeutics, LLC | Rezzayo (Drug), Kimyrsa, Vabomere | Food and Beverage | In-kind items and services | $22.13 | General |
| Category: ANTIFUNGALS | ||||||
| 08/14/2023 | QOL Medical, LLC | Sucraid (Drug) | Food and Beverage | Cash or cash equivalent | $15.61 | General |
| Category: THERAPY FOR CSID | ||||||
| 07/19/2023 | QOL Medical, LLC | Sucraid (Drug) | Food and Beverage | Cash or cash equivalent | $11.87 | General |
| Category: THERAPY FOR CSID | ||||||
| 03/17/2023 | Amgen Inc. | AMJEVITA (Biological), AVSOLA | Food and Beverage | In-kind items and services | $13.82 | General |
| Category: Inflammation | ||||||
| 12/01/2022 | Alnylam Pharmaceuticals Inc. | GIVLAARI (Drug) | Food and Beverage | In-kind items and services | $13.13 | General |
| Category: Genetic Disease | ||||||
| 08/04/2022 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $22.36 | General |
| Category: INTERNAL MEDICINE | ||||||
| 08/02/2022 | INTERCEPT PHARMACEUTICALS, INC. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $25.88 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 07/21/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $22.05 | General |
| Category: Gastroenterology | ||||||
| 06/20/2022 | Alnylam Pharmaceuticals Inc. | GIVLAARI (Drug) | Food and Beverage | In-kind items and services | $29.34 | General |
| Category: Genetic Disease | ||||||
| 04/13/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.07 | General |
| Category: Gastroenterology | ||||||
| 02/01/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: Gastroenterology | ||||||
| 10/26/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.09 | General |
| Category: Gastroenterology | ||||||
| 04/16/2021 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $22.30 | General |
| 12/07/2020 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $11.86 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/23/2020 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $70.90 | General |
| 12/12/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.87 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/06/2018 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $19.27 | General |
| Category: Cardiovascular | ||||||
| 11/30/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/08/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $20.60 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/27/2018 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $19.46 | General |
| Category: Cardiovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 177 | 241 | $78,601 | $19,846 |
| 2022 | 6 | 131 | 174 | $55,116 | $14,931 |
| 2021 | 8 | 201 | 349 | $119,686 | $31,655 |
| 2020 | 4 | 51 | 78 | $22,400 | $5,834 |
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 53 | 68 | $19,856 | $5,013 | 25.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 23 | 50 | $13,840 | $3,673 | 26.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 28 | 30 | $12,839 | $3,628 | 28.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 17 | 17 | $10,934 | $2,618 | 23.9% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 25 | 27 | $11,653 | $2,147 | 18.4% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 16 | 33 | $4,983 | $1,557 | 31.2% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 15 | 16 | $4,496 | $1,211 | 26.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 57 | 75 | $21,900 | $6,185 | 28.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 19 | 19 | $11,622 | $3,110 | 26.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 14 | 31 | $8,369 | $2,095 | 25.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 15 | 16 | $6,736 | $1,965 | 29.2% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 15 | 22 | $3,398 | $824.42 | 24.3% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 11 | 11 | $3,091 | $751.93 | 24.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 35 | 162 | $44,712 | $10,946 | 24.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 32 | 41 | $17,261 | $4,550 | 26.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 45 | 52 | $15,184 | $4,448 | 29.3% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 17 | 17 | $12,705 | $3,524 | 27.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 17 | 17 | $8,344 | $2,466 | 29.6% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 18 | 19 | $9,771 | $2,275 | 23.3% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 21 | 21 | $6,089 | $2,072 | 34.0% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 16 | 20 | $5,620 | $1,373 | 24.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 15 | 39 | $10,608 | $2,645 | 24.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 12 | 14 | $5,678 | $1,245 | 21.9% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2020 | 11 | 12 | $2,498 | $1,080 | 43.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 13 | 13 | $3,616 | $863.88 | 23.9% |
About Dr. Bernard Partiula, D.O
Dr. Bernard Partiula, D.O is a Student in an Organized Health Care Education/Training Program healthcare provider based in Valhalla, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/25/2015. The National Provider Identifier (NPI) number assigned to this provider is 1417341645.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bernard Partiula, D.O has received a total of $619.51 in payments from pharmaceutical and medical device companies, with $90.74 received in 2024. These payments were reported across 24 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($619.51).
As a Medicare-enrolled provider, Partiula has provided services to 560 Medicare beneficiaries, totaling 842 services with total Medicare billing of $72,266. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Internal Medicine
- Location Valhalla, NY
- Active Since 03/25/2015
- Last Updated 02/22/2021
- Taxonomy Code 390200000X
- Entity Type Individual
- NPI Number 1417341645
Products in Payments
- XARELTO (Drug) $162.46
- XIFAXAN (Drug) $119.27
- GIVLAARI (Drug) $42.47
- ELIQUIS (Drug) $38.73
- CUVRIOR (Drug) $30.07
- Sucraid (Drug) $27.48
- OCALIVA (Drug) $25.88
- ENTYVIO (Biological) $22.36
- Rezzayo (Drug) $22.13
- IQIRVO (Drug) $21.64
- AMJEVITA (Biological) $13.82
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Valhalla
Eitan Glucksman, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $30,301
Jasnit Makkar, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $15,870
Dr. Tasleem Katchi, M.b.b.s, M.B.B.S
Student in an Organized Health Care Education/Training Program — Payments: $7,795
Dr. Logan Carr, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $6,431
Dr. Gabriel Froula, D.o, D.O
Student in an Organized Health Care Education/Training Program — Payments: $4,560
Dr. Ethan Paulin, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $4,429